Sauerland Carmel, Engelking Constance, Wickham Rita, Corbi Dominick
Nursing Cancer Center, Westchester Medical Center, Valhalla, NY, USA.
Oncol Nurs Forum. 2006 Nov 27;33(6):1134-41. doi: 10.1188/06.ONF.1134-1141.
PURPOSE/OBJECTIVES: To review the literature regarding the incidence, current practice, guideline recommendations, nursing management, and knowledge gaps relevant to vesicant extravasation.
Published research articles, books, case reports, and national guidelines.
Vesicant extravasation is a relatively rare but significant complication of chemotherapy administration. Extravasation may have a range of consequences that can cause serious physical and quality-of-life effects. Knowledge of risk factors and preventive measures can reduce patient risk. Data-based and empirical management strategies such as immediate local measures (agent withdrawal, comfort measures, and medical interventions) may minimize risk for extravasation, as well as lead to timely recognition and management and decreased morbidity should extravasation occur.
Vesicant extravasation and sequelae constitute a complex patient problem that clinicians should strive to prevent or to minimize injury should it occur. To this end, clinicians must demonstrate awareness of risks and use specialized knowledge while administering vesicant agents.
Only nurses knowledgeable about extravasation and skilled in associated techniques should assume responsibility for vesicant administration.
目的/目标:回顾有关发泡剂外渗的发生率、当前实践、指南建议、护理管理及相关知识空白的文献。
已发表的研究文章、书籍、病例报告及国家指南。
发泡剂外渗是化疗给药相对罕见但严重的并发症。外渗可能产生一系列后果,可导致严重的身体影响及生活质量下降。了解危险因素和预防措施可降低患者风险。基于数据和经验的管理策略,如立即采取局部措施(药物撤出、舒适措施及医疗干预),可将外渗风险降至最低,若发生外渗,还可实现及时识别与管理并降低发病率。
发泡剂外渗及其后遗症构成复杂的患者问题,临床医生应努力预防,若发生应尽量减少损伤。为此,临床医生在给予发泡剂时必须意识到风险并运用专业知识。
只有了解外渗知识并掌握相关技术的护士才应负责给予发泡剂。